Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Albuminuria
100%
Intensive Blood Pressure Control
100%
EGFR Decline
54%
Systolic BP
36%
Albumin-to-creatinine Ratio
36%
Hazard Ratio
27%
Cardiovascular Mortality
18%
Systolic Blood Pressure Intervention Trial (SPRINT)
18%
Cardiovascular Events
18%
Relative Scale
18%
95% Confidence Interval
18%
All-cause Mortality
9%
High Cardiovascular Risk
9%
Hazard Risk
9%
BP Targets
9%
Incidence Rate
9%
Beneficial Effects
9%
Absolute Risk Difference
9%
Absolute Risk
9%
Composite Outcome
9%
Absolute Scale
9%
Non-diabetic Adults
9%
BP Control
9%
Absolute Benefit
9%
Home BP
9%
Urinary Albumin-to-creatinine Ratio
9%
Difference Ratio
9%
Medicine and Dentistry
Blood Pressure
100%
Albuminuria
100%
Pressure Control
100%
Creatinine
45%
Albumin
45%
Hazard Ratio
27%
Cardiovascular System
27%
Systolic Blood Pressure
18%
Intervention Trial
18%
Cardiovascular Risk
9%
Attributable Risk
9%
Median Follow Up
9%
Nursing and Health Professions
Blood Pressure
100%
Albuminuria
100%
Pressure Control
100%
Creatinine
45%
Albumin
45%
Hazard Ratio
27%
Cardiovascular System
27%
Systolic Blood Pressure
18%
Confidence Interval
18%
Cardiovascular Risk
9%
Attributable Risk
9%
Pharmacology, Toxicology and Pharmaceutical Science
Albuminuria
100%
Creatinine
45%
Albumin
45%
Intervention Trial
18%
Cardiovascular Risk
9%